macht GENUS (GGNS) nochmals 100% - 500 Beiträge pro Seite

[xanda1]

Genus (GGNS) ist im bereich chip-
ausrüster tätig.
in den vergangenen wochen wurden
hohe auftragseingänge gemeldet.
die für 2001 geplanten aufträge
hat man bereits jetzt erreicht.

zusätzliche fantasie ergibt sich
durch die entwicklung der
"atomic-layer-technologie" die
auch in zukunft für umsätze
sorgen soll.

[621Paul]

Cuttingedge empfhiehlt:
Jetzt wieder einsteigen bei Genus WKNR:876975.
Kursziel 13 USD. Stopp 4 USD.

Genus ist Lieferant von Systemen zum Abscheiden von Dünnfilmschichten zur Produktion von Halbleitern sowie Flachbildschirme, Fotomasken, Komponenten für mikromechanischen Bauteilen (MEMS) und Festplattenlaufwerke.

MfG 621Paul

[Skotty001]

Hi ihr 2 einsamen schreiber ich wollt nur sagen ich bin heute zu 7Euro rein, habe den Kurs erstmal ein wennig beobachtet und nun erstmalig auf CuttingEdge gehört !
Auf steigende Kurse !!!

MFG Skotty

[dpascal]

@621Paul
@Skotty001

Hey,
Der Chart von Genus sieht z.Zt. super aus!
Steigende Kurse bei steigendem Umsatz ist auck nicht schlecht.
Nun zu Cutting Edge: Lohnt sich ein Abo??? Otmar Weber ist ja eigentlich kein schlechter, wenn es um Small Caps geht.

Für Antworten bedanke ich mich im voraus!!!!

[Skotty001]

@dpaskal

Hi,
erstmal zu deiner frage wegen dem CE-ABO ich bin noch nicht so lange dabei aber die Tips sind echt nicht schlecht !
Würde dir empfehlen es mal mit einem Monat Probelesen zu versuchen, wenn du begeistert bist wie ich dann nehme die kosten für das ABO in kauf !
nun zu Genus: Gestern wurde der Kurs in US ganzschön gebeutelt fast 10% verlust gehen auch an der deutschen Börse nicht spurlos vorbei daher auch heute der Kursverlust >dalachenmirmaldrüber< :-)
Heute hat GGNS in US im plus geschlossen daher geh ich davon aus das wir morgen auch leicht im plus eröffnen wenn die stimmung am markt so bleibt sollten wir spätestens mitte der nächsten Woche 7$ sehen.
Euch und mir viel Glück bei GGNS
bis die Tage
MFG Skotty

[humphy]

Hi,

nun sind wir schon 4. Bin letzte Woche bei €6 rein. GGNS hält am 01.08.01 eine Analystenkonferenz über die Q2 Zahlen ab und in US erwartet man sogar eine Anhebung der Planzahlen. Könnte ne spannende Woche werden.

Zu CE: Bei Otti ist es wie bei anderen Börsenbriefen, mal liegen sie richtig mal liegen sie falsch. Habe mir einige Werte letztes Jahr in meine Watchlist genommen und da lag er ganz schön daneben. Im Juni hat er gerade einen seiner früheren Lieblinge ( Xybernaut ) niedergemacht, obwohl die Company durch ein Lizenzabkommen mit Hitachi vor dem großen Durchbruch steht.

Hat jemand von euch den Aktionär gelesen? Angeblich soll GGNS letzte Woche als spekulativer Top Tip empfohlen worden sein?

humphy

[perforator]

bin ich der einzigste der noch zockt

[xanda1]

ich habe nach der meldung
über den patentstreit mit AMSI
verkauft.
es wurde zwar viel geschrieben,
dass der patentstreit kaum einfluss
auf die zukünftige geschäftsentwicklung
haben soll, aber der kurs wird durch so
eine meldung bei einem kleinen
unternehmen (fast)immer negativ
beeinflusst.
nun ist ja der kurs ordentlich zurück-
gekommen. wenn man mit guten nerven
ausgestattet ist kann man mit etwas
glück profitieren.

ob das in diesen zeiten wichtig ist,
ist eine andere frage.

[Pozzo]

Chart angucken!
Die 2 hat krass gehalten,kurzzeitige Erholung bis 3,5 sollte bevorstehen,ist einfach zusehr abgestürzt.
-
Pozzo

[perforator]

@pozzo

mach dir mal keine sorgen die kommt wieder.

[humphy]

Hi Pozzo,

erst xybr und jetzt Genus - wieviel gemeinsame Leichen haben wir noch im Keller?

Kaufst Du nochmal nach?

Gruß humphy

[perforator]

unter 2€ nachkaufen! bei welchem kurs seit ihr eingestiegen ?

[Pozzo]

Hab knapp unter 2 nachgekauft und den ganzen Haufen bei 2,35
wieder rausgehauen.
Habe die Lust an long verloren,versuche mich in "Depotrettung",trotz Ottmars "buy".
xybr bleibt erstmal drin,wie lange weiss nur der intraday chart.
Luck!
-
Pozzo

[humphy]

Hi Pozzo

Gewinn mitnehmen ist nie verkehrt, aber ich würde nicht zuviel hoppen. Leider war ich die letzten Wochen viel unterwegs und habe die guten Einstiegskurse verpasst. Mit den Veröffentlichungen der Q3 Ergebnisse werden wir aber nochmals die Tiefstständes testen. xybr würde ich nicht nach dem Intraday Chart beurteilen. Hier bleibe ich absolut LONG und kaufe bei $ 1,2 - 1,5 nach. Bedenke, im November kommt Hitachi mit dem Consumer Modell.

@perforator

€ 3,1 und 6,0 mit dem Nachkauf warte ich ab. Auch Genus kommt spätestens im Frühjahr wieder.

Viel Erfolg
humphy

[perforator]

bin bei 4,88€ rein. wann kommen denn die zahlen??

[humphy]

@perforator

Ich glaube so um den 1. November.

humphy

[perforator]

Zahlen müßten um den 20 bis 25.Okt kommen.

[humphy]

Ich überlege gerade ob ich meine Genus am Montag verkaufe und mir dafür nen schönen Nasdaq Put zulege??

humphy

[perforator]

kann man sich überlegen ist halt riskant

[humphy]

Die Q3 Zahlen kommen am Montag nach Marktschluss und am Dienstag gibts den Conf. Call.

humphy

[TCee]

Genus Reports Third Quarter 2001 Results

11/5/2001 6:22:00 PM
SUNNYVALE, Calif., Nov 5, 2001 /PRNewswire via COMTEX/ -- Genus, Inc. (GGNS) reported financial results for its third quarter ended September 30, 2001. Net sales were $15.1 million, representing a four percent increase over the $14.5 million in net sales for the same quarter of 2000 and an 11 percent increase sequentially. Net loss for the third quarter was $744,000 or $0.03 per diluted share, compared to net income of $1.6 million, or $0.08 per share in the same quarter of 2000.

For the nine months ending September 30, 2001, revenue was $43.1 million, representing 73 percent growth over the corresponding period in 2000. Net loss for the nine months ending September 30, 2001 was $1.5 million or $0.07 per share, compared to a net loss of $10.8 million or $0.57 per share for the same period in 2000.

The decline in net income in the third quarter of 2001 compared to third quarter of 2000 was primarily due to lower gross profits, which were down $1.7 million, and higher R&D expenses, which were up $600,000. Gross profit as a percentage of revenues declined to 32 percent in the third quarter from 45 percent in the same quarter of 2000, and was driven by higher manufacturing variances and approximately $600,000 of inventory write-offs and other non-recurring adjustments. In June, the company launched initiatives in the plant to improve workflow, reduce inventories, and significantly increase production capacity in the company`s new multi-product, multi-film, multi-customer environment. Although these actions helped Genus to reduce inventories by $8 million and to increase shop floor production capacity to 15 systems per quarter, they also resulted in higher manufacturing inefficiencies.

There were no new systems booked in the third quarter. However, customer activity remains high and a number of Genus` products are currently in advanced stages of evaluations with several customers. Year-to-date bookings for the nine months ended September 30 were $28.3 million compared to year-to-date shipments of $30.7 million.

Looking forward, Genus expects its fourth quarter results to be impacted by the current trough in the semiconductor industry. With third quarter system shipments at $11 million, the company expects revenue in the fourth quarter to be in the $7 to $9 million range.

Bill Elder, CEO of Genus commented, "Despite the current downturn, there are exciting developments taking place at Genus and in the industry. We entered the year with three customers; now we have seven and expect to exit the year with a total of eight customers. Atomic layer deposition (ALD) technology has all but won full validation this year from the semiconductor industry and the data storage industry. At Genus, we have been showcasing our ALD technology to many potential customers in our newly expanded demo facility. New technology such as ALD should fuel the next upturn for the semiconductor industry."

Customer interest in Genus remains high in three important areas. First there is the data storage industry. Having gained a leading manufacturer of thin film heads as a new customer earlier this year, Genus is now actively engaged with several other leading manufacturers in the data storage industry. The second area is the capacitor business for semiconductors. Genus is confident it will continue to cultivate near term business in the capacitor market for ALD films. Third, the company`s core product, tungsten CVD (chemical vapor deposition), continues to receive signals of future customer spending for both 200mm and 300mm systems in 2002.

Elder added, "We shipped our Lynx3 tungsten product for 300mm production this quarter and we will ship our first 300mm system for ALD during the fourth quarter. We are now positioned to be a contender in the emerging 300 mm marketplace."

In response to the uncertain outlook for the coming quarters, Genus has implemented several cost-cutting measures in order to improve profitability and sustain a break-even position in operating cash flow. In October, the company reduced its headcount by 15 percent and implemented several other measures to reduce its overall spending run-rate by 20 percent. In addition, the company is actively managing its capital expenditures and working capital. These efforts have already started paying off with inventory levels down 40 percent compared to levels on June 30, 2001.

Conference Call Information

Tomorrow morning, Dr. William Elder and Shum Mukherjee will discuss Genus` Q3 results during the scheduled conference call with financial analysts. The conference call will be held at 8:00 a.m. Pacific Time on Tuesday, November 6, and will be simultaneously webcast to the public. The live webcast will be accessible at www.genus.com or at www.companyboardroom.com. Telephone replay of the call will be available at 402-998-1273 shortly after the actual call and until 6:00 p.m. on Friday, November 9, 2001. An archived copy of the webcast will be available online until November 23, 2001.

Forward-Looking Statements

This press release contains forward-looking statements regarding the company`s future financial and business performance. These forward-looking statements are subject to a number of risks and uncertainties. These contingencies include but are not limited to: the actual customer orders received by the company, the extent to which ALD technology is demanded by the marketplace, the timing of final acceptance of products by customers, the financial climate and accessibility to financing, general conditions in the thin film equipment market and in the macro-economy, and the influence of global political events. Genus assumes no obligation to update this information. Additional risks and uncertainties are discussed in the Management`s Discussion and Analysis of Results of Operations contained in Genus` Annual Report on Form 10-K/A for the fiscal year ended December 31, 2000 and subsequent quarterly reports on Form 10-Q filed with the Securities and Exchange Commission.

About Genus

Genus, Inc. manufactures and sells capital equipment and advanced deposition processes for leading manufacturers in the semiconductor industry and in non-semiconductor industries such as the data storage market. Genus offers its Lynx series production-proven equipment for 200mm and 300mm processing, and offers thin film deposition modules for chemical vapor deposition (CVD), atomic layer deposition (ALD), and pre-clean capabilities. The deposition processes are used to manufacture integrated circuits for the computer, communications, medical, military, transportation and consumer electronics industries. Genus` customers include semiconductor manufacturers located throughout the United States, Europe and the Pacific Rim including Korea, Japan and Taiwan. Founded in 1981, the company is headquartered in Sunnyvale, California. For additional information visit Genus` web site at www.genus.com. Lynx2(R) and Lynx3(TM) are trademarks of Genus, Inc.

Exhibit 1
Genus, Inc. Condensed Consolidated Statement of Operations (unaudited)

Exhibit 2
Genus, Inc. Condensed Consolidated Balance Sheets (unaudited)


Exhibit 1
Genus, Inc.
Condensed Consolidated Statement of Operations (Unaudited)
(Amounts in thousands, except per share data)


Three Months Ended Nine Months Ended
September 30, September 30,
2001 2000 2001 2000

Net sales $15,094 $14,543 $43,062 $24,955

Costs and expenses:
Cost of goods sold 10,300 8,044 27,523 15,063
Research and development 2,592 2,034 8,838 5,762
Selling, general and
administrative 2,739 2,820 7,971 8,043
Income (loss) from
operations (537) 1,645 (1,270) (3,913)

Other, net (207) 101 (127) 383
Income (loss) before income
taxes (744) 1,746 (1,397) (3,530)

Provision for income taxes -- 100 69 450

Net income (loss) before
cumulative
effect of change in accounting
principle (744) 1,646 (1,466) (3,980)

Cumulative effect of change in
accounting principle -- -- -- (6,770)

Net income (loss) $(744) $1,646 $(1,466) $(10,750)

Net income (loss) per common
share and
per common share assuming
basic shares $(0.03) $0.09 $(0.07) $(0.57)

Net income (loss) per common
share and
per common share assuming
dilution $(0.03) $0.08 $(0.07) $(0.57)

Shares used in per share
calculations-basic 22,268 19,126 20,793 18,845
Shares used in per share
calculations-diluted 22,268 20,593 20,793 18,845


Exhibit 2
Genus, Inc.
Condensed Consolidated Balance Sheets (Unaudited)
(Amounts in thousands)

September 30, December 31,
2001 2000
Assets
Cash and cash equivalents $5,514 $3,136
Accounts receivable, net 5,041 8,479
Inventories 11,956 21,849
Other current assets 763 675
Total current assets 23,274 34,139

Property and equipment, net 15,940 10,207
Other assets, net 250 189
Total assets $39,464 $44,535

Liabilities, redeemable
preferred stock,
and shareholders` equity
Deferred revenue $4,390 $18,562
Other current liabilities 17,737 14,681
Shareholders` equity 17,337 11,292
Total liabilities, redeemable
preferred stock,
and shareholders` equity $39,464 $44,535

MAKE YOUR OPINION COUNT - Click Here
http://tbutton.prnewswire.com/prn/11690X95943553

SOURCE Genus, Inc.

CONTACT: Debra Scott of Genus, Inc., [phone], ext. 1407, or
[e-mail]; or Dave Richardson of Positio, [phone], ext. 108, or
[e-mail], for Genus, Inc.

URL: http://www.companyboardroom.com
http://www.genus.com
http://www.prnewswire.com

[humphy]

Bin ich froh, dass ich die Stücke nicht verkauft habe. Perforator, Pozzo seit ihr noch dabei?

humphy

[perforator]

klar bin noch dabei, habe aber einen teil meiner aktien verkauft und in vgr und inkp investiert.

[humphy]

perforator,

werde mir mal deine Tipps anschauen. Was erwartest Du von den beiden?
humphy

[perforator]

vgr denke ich wird ne langfristige sache deshalb versuche ich im moment meine teile los zu werden um im januar wieder einzusteigen. das geld werde ich so lange in inkp stecken, die hat mir schon mal 60% gebracht **G*.

mit genus bin ich jetzt nur noch 20% im minus das macht freude !!

cya

[Pozzo]

Bin draussen,schon etwas länger,habe generell meine Taktik geändert,nur noch kurzfristig.
Da kommt mir aber GGNS wieder in die Quere,wenn Volumen kommt.dann bin ich auch wieder dabei,Ausbruch bei 3,45 und das Teil läuft schnurstracks zur 4.
Denke ernsthaft über Einstieg nach.
-
Pozzo

[Pozzo]

Sollte am Montag die 3 halten bin ich ab Kursen über 3,1 wieder an Bord,sollte die Unterstützung halten,wie gesagt.
Was gibts neues aus den Ami-Boards?
Glück auf!
-
Pozzo

[humphy]

Ich denke auch über einen Nachkauf nach, aber ich warte noch ab. Zwischen den Jahren ( tax loss selling ) könnten wir nochmals Kurse bei 2,50 sehen. Das gleiche gilt für unsere XYBR.
humphy

[humphy]

Pozzo,

ich hoffe nicht, dass Du bei 3,10 wieder eingestiegen bist?

humphy

[IngoBerndt]

Also ich bin eingestiegen ich hoffe ihr zieht mit nächste Woche passiert was.

[humphy]

Genus gewinnt neuen Kunden!

Genus Wins New ALD Customer for Non-Semiconductor Applications
Latest Order Further Indication of Rapid Commercialization of ALD
SUNNYVALE, Calif., Jan. 10 /PRNewswire-FirstCall/ -- Following a recent announcement relating to the rapid commercialization of its atomic layer deposition (ALD) technology, Genus, Inc. (Nasdaq: GGNS - news) announced today that it has received an order for its ALD technology from the world`s largest manufacturer of disc drives, magnetic discs and thin-film heads. This marks Genus` second ALD customer in non-semiconductor market applications.

Following the recent Read-Rite announcement, this order is a major breakthrough for Genus as it represents another order from a tier-one market leader in the thin-film head business. These announcements further support the ``phase II ALD rapid commercialization`` program implemented by Genus in early December 2001. The new customer has ordered the LYNX2® ALD product line for depositing high-k dielectric aluminum oxide thin films in magnetic heads. Shipment is scheduled for the first quarter of 2002.

``Full commercialization and acceptance of ALD is clearly a reality, and as the market and technology leader we`ll continue to capitalize on our proven leadership and competitive advantage at this time,`` said Bill Elder, Genus` president and CEO. ``We`re further excited because this new customer broadens our customer base in non-semiconductor applications, demonstrating the clear performance advantages of using ALD and displacing the incumbent technology. In the bigger picture it is another boost for the adoption of ALD technology.``

Werner Rust, the newly appointed vice president of worldwide sales and marketing, indicated, ``This business is key to our growth and acceptance in the data storage market. Based on our success here and previously with Read-Rite Corporation, this order will act as a pivot point to expand the customer base within this and potentially other markets.``

Forward-Looking Statements

This press release contains forward-looking statements regarding the company`s future financial and business performance. These forward-looking statements are subject to a number of risks and uncertainties. These contingencies include but are not limited to: actual customer orders received by the company, the extent to which ALD technology is demanded by the marketplace, the actual number of customer orders received by the company, the timing of final acceptance of products by customers, the financial climate and accessibility to financing, general conditions in the thin film equipment market and in the macro-economy, and the influence of global political events. Genus assumes no obligation to update this information. Additional risks and uncertainties are discussed in the Management`s Discussion and Analysis of Results of Operations contained in Genus` Annual Report on Form 10-K/A for the fiscal year ended December 31, 2000 and subsequent quarterly reports on Form 10-Q filed with the Securities and Exchange Commission.

humphy

[IngoBerndt]

ich kann euch nur raten kauft.

[humphy]

Mit dem Auftrag könnte die Reise weiter gehen. Kann das Infineon sein?

Genus Secures 200 mm Multi-System ALD Order From Major DRAM Manufacturer
Monday August 11, 8:02 am ET
First to Take ALD to 90 nm Advanced DRAM Production


SUNNYVALE, Calif., Aug. 11 /PRNewswire-FirstCall/ -- Genus, Inc. (Nasdaq: GGNS - News), a leader in advanced thin film deposition equipment used to manufacture semiconductor and data storage devices, today announced multiple orders for its StrataGem200 ALD tool from a major European DRAM manufacturer. This order marks the second DRAM maker to put Genus ALD tools into production.
ADVERTISEMENT


The DRAM maker will implement the ALD technology into 200 mm production at the 90 nm node, the most advanced technology node currently to use ALD technology. To enhance production capability, these StrataGem systems incorporate significant hardware and technology improvements that provide next-generation ALD capability, improved maintainability and enhanced production worthiness.

"This is the first customer to adopt ALD for 90 nm production," said Bill Elder, CEO of Genus, Inc. "It is a testament to the flexibility and extendibility of our StrataGem tools. These systems continue to attract customers with their ability to go beyond current deposition capabilities. In addition, we have a very focused customer strategy, with sales and support centers around the world, to ensure the highest quality of service and local support."

"At the 110 nm node, ALD has started to penetrate DRAM production lines for capacitor applications in semiconductor manufacturing because of its ability to deposit advanced dielectrics with a considerably higher k value than was previously available," said Werner Rust, executive vice president of global sales and marketing. "Genus continues to push ALD migration. The company has made some major investments during the past three years in both manufacturing and applications, specifically in order to tailor processes to customers` needs, and we are now seeing significant returns."

humphy

[humphy]

und noch ne Order.

Major U.S. Data Storage Manufacturer Increases ALD Capacity
Wednesday August 13, 8:01 am ET


SUNNYVALE, Calif., Aug. 13 /PRNewswire-FirstCall/ -- Genus, Inc. (Nasdaq: GGNS - News), a leader in advanced thin film deposition equipment used to manufacture semiconductor and data storage devices, has received a follow on purchase order for additional ALD manufacturing capacity from a major U.S. data storage manufacturer. This customer uses ALD for the manufacturing of thin film heads (TFH), and the order represents an increase in ALD capacity at this manufacturing location.
ADVERTISEMENT


"This purchase order continues the validation of ALD as a manufacturing process for advanced TFH in the data storage industry," commented Werner Rust, vice president of sales and marketing at Genus. "Our TFH customers have extended their current manufacturing process beyond what was possible with other deposition techniques, in addition to experiencing greater yields at a lower cost of ownership. The decision to adopt our ALD technology is very much in keeping with the customers` desire to invest in leading-edge production grade technology that allows them to expand leadership in the global TFH industry."

humphy

[humphy]

Adam, Harkness & Hill - upgrade von Buy auf Strong Buy - Kursziel USD 8

Genus ist Geil
humphy